Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/de-gruyter/synthesis-of-thiophene-and-n-substituted-thieno-3-2-d-pyrimidine-0yVyVh4TQB
- Publisher
- de Gruyter
- Copyright
- © 2017 Hend N. Hafez et al., published by De Gruyter Open
- ISSN
- 1846-9558
- eISSN
- 1846-9558
- DOI
- 10.1515/acph-2017-0028
- pmid
- 28858838
- Publisher site
- See Article on Publisher Site
Abstract
REFERENCES1. H. N. Hafez and A. B. A. El-Gazzar, Design and synthesis of 3-pyrazolyl-thiophene, thieno[2,3-d] pyrimidines as new bioactive and pharmacological activities, Bioorg. Med. Chem. Lett. 18 (2008) 5222–5227; DOI: 10.1016/j.bmcl.2008.08.071.http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000259326800015&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f310.1016/j.bmcl.2008.08.0712. S. Abbas, M. Hussain, S. Ali, M. Parvez, A. Raza, A. Haider and J. Iqbal, Structural, enzyme inhibition, antibacterial and DNA protection studies of organotin(IV) derivatives of thiophene-2-carboxylic acid, J. Organomet. Chem. 724 (2013) 255–261; DOI: 10.1016/j.jorganchem.2012.11.033.10.1016/j.jorganchem.2012.11.033http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000314113400035&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f33. Y. Ni. A. Gopalsamy, D. Cole, Y. Hu, R. Denny, M. Lpek, J. Liu, J. Lee, J. P. Hall, M. Luong, J. B. Telliez and L. L. Lin, Identification and SAR of a new series of thieno[3,2-d]pyrimidines as Tpl2 kinase inhibitors, Bioorg. Med. Chem. Lett. 21 (2011) 5952–5956; DOI: 10.1016/j.bmcl.2011.07.069.10.1016/j.bmcl.2011.07.0694. T. P. Heffron, M. Berry, G. Castanedo, C. Chang, I. Chuckowree, J. Dotson, A. Folkes, J. Gunzner, J. D. Lesnick, C. Lewis, S. Mathieu, J. Nonomiya, A. Olivero, J. Pang, D. Peterson, L. Salphati, D. Sampath, S. Sideris, D. P. Sutherlin, V. Tsui, N. C. Wan, S. Wang, S. Wong and B. Y. Zhu, Identification of GNE-477, a potent and efficacious dual PI3K/mTOR inhibitor, Bioorg. Med. Chem. Lett. 20 (2010) 2408–2411; DOI: 10.1016/j.bmcl.2010.03.046.10.1016/j.bmcl.2010.03.0465. Q. Tan, Z. Zhang, J. Hui, Y. Zhao and L. Zhu, Synthesis and anticancer activities of thieno [3,2-d] pyrimidines as novel HDAC inhibitors, Bioorg. Med. Chem. 22 (2014) 358–365; DOI: 10.1016/j.bmc.2013.11.021.10.1016/j.bmc.2013.11.021http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000329068400032&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f36. J. Kim, J. Kwon, D. Lee, S. Jo, O. Dongsik, C. Jihyun, E. Park, J. Y. Hwang, Y. Ko, I. Choi, M. K. Ju, J. Ahn, J. Kim, S.-J. Han, T.-H. Kim, J. Cechetto, J. Nam, S. Ahn, P. Sommer, M. Liuzzi and J. Lee, Serendipitous discovery of 2-((phenylsulfonyl)methyl)-thieno[3,2-d]pyrimidine derivatives as novel HIV-1 replication inhibitors, Bioorg. Med. Chem Lett. 24 (2014) 5473–5477; DOI: 10.1016/j.bmcl.2014.10.007.10.1016/j.bmcl.2014.10.007http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000345125500027&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f37. K. W. Temburnikar, S. C. Zimmermann, N. T. Kim, C. R. Ross, C. Gelbmann, C. E. Salomon, G. M. Wilson, J. Balzarini and K. L. Seley-Radtke, Antiproliferative activities of halogenated thieno[3,2-d] pyrimidines, Bioorg. Med. Chem. 22 (2014) 2113–2122; DOI: 10.1016/j.bmc.2014.02.033.http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000334337800011&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f310.1016/j.bmc.2014.02.0338. A. J. Folkes, K. Ahmadi, W. K. Alderton, S. Alix, S. J. Baker, G. Box, I. S. Chuckowree, P. A. Clarke, P. Depledge, S. A. Eccles, L. S. Friedman, A. Hayes, T. C. Hancox, A. Kugendradas, L. Lensun, P. Moore, A. G. Olivero, J. Pang, S. Patel, G. H. Pergl-Wilson, F. I. Raynaud, A. Robson, N. Saghir, L. Salphati, S. Sohal, M. H. Ultsch, M. Valenti, H. J. A. Wallweber, N. C. Wan, C. Wiesmann, P. Workman, A. Zhyvoloup, M. J. Zvelebil and S. J. Shuttleworth, The identification of 2-(1H-indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine (GDC-0941) as a potent, selective, orally bioavailable inhibitor of class I PI3 kinase for the treatment of cancer, J. Med. Chem. 51 (2008) 5522–5532; DOI: 10.1021/jm800295d.http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000259342700007&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f310.1021/jm800295d9. K. A. Chakraborti, B. Gopalakrishnan, M. E. Sobhia and M. Alpeshkumar, 3D-QSAR studies on thieno [3,2-d] pyrimidines as phosphodiesterase IV inhibitors, Bioorg. Med. Chem. Lett. 13 (2003) 1403–1408; DOI: 10.1016/S0960–894X(03)00172-0.10.1016/S0960894X(03)00172-010. H. N. Hafez, H. A. R. Hussein and A. B. A. El-Gazzar, Synthesis of substituted thieno[2,3-d]pyrimidine-2,4-dithiones and their S-glycoside analogues as potential antiviral and antibacterial agents, Eur. J. Med. Chem. 45 (2010) 4026–4034; DOI: 10.1016/j.ejmech.2010.05.060.10.1016/j.ejmech.2010.05.060http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000281568600062&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f311. H. N. Hafez, A. B. A. El-Gazzar and M. E. A. Zaki, Simple approach to thieno[3,2-d]-pyrimidines as new scaff olds of antimicrobial activities, Acta Pharm. 66 (2016) 331–351; DOI: 10.1515/acph-2016-0029.10.1515/acph-2016-002912. H. N. Hafez, A. B. A. El-Gazzar and G. A. M. Nawwar, Synthesis, biological and medicinal significance of S-glycosido-thieno[2,3-d]-pyrimidines as new anti-inflammatory and analgesic agents, Eur. J. Med. Chem. 45 (2010) 1485–1493; DOI: 10.1016/j.ejmech.2009.12.056.10.1016/j.ejmech.2009.12.05613. H. N. Hafez and A. B. A. El-Gazzar, Design and synthesis of 3-pyrazolyl-thiophene, thieno[2,3-d] pyrimidines as new bioactive and pharmacological activity, Bioorg. Med. Chem. Lett. 18 (2008) 5222–5227; DOI: 10.1016/j.bmcl.2008.08.071.10.1016/j.bmcl.2008.08.07114. Z. Liu, S. Wu, Y. Wang, R. Li, J. Wang, L. Wang, Y. Zhao and P. Gong, Design, synthesis and biological evaluation of novel thieno[3,2-d] pyrimidine derivatives possessing diaryl semicarbazone scaff olds as potent antitumor agents, Eur. J. Med. Chem. 87 (2014) 782–793; DOI: 10.1016/j.ejmech.2014.10.022.10.1016/j.ejmech.2014.10.02215. M. E. Welker and G. R. Kulik, Synthesis of PI3K/Akt/mTOR signaling pathway inhibitors, Bioorg. Med. Chem. 21 (2013) 4063–4091; DOI: 10.1016/j.bmc.2013.04.083.10.1016/j.bmc.2013.04.08316. E. Perspicace, V. Jouan-Hureaux, R. Ragno, F. Ballante, S. Sartini, C. La Motta, F. Da Settimo, B. Chen, G. Kirsch, S. Schneider, B. Faivre and S. Hesse, Design, synthesis and biological evaluation of new classes of thieno[3,2-d]pyrimidinone and thieno[1,2,3]triazine as inhibitor of vascular endothelial growth factor receptor-2 (VEGFR-2), Eur. J. Med. Chem. 63 (2013) 765–781; DOI: 10.1016/j.ejmech.2013.03.022.10.1016/j.ejmech.2013.03.02217. T. R. Rheault, T. R. Caferro, S. H. Dickerson, K. H. Donaldson, M. D. Gaul, A. S. Goetz, R. J. Mullin, O. B. McDonald, K. G. Petrov, D. W. Rusnak, L. M. Shewchuk, G. M. Spehar, A. T. Truesdale, D. E. Vanderwall, E. R. Wood and D. E. Uehling, Thienopyrimidine-based dual EGFR/ErbB-2 inhibitors, Bioorg. Med. Chem. Lett. 19 (2009) 817–820; DOI: 10.1016/j.bmcl.2008.12.011.10.1016/j.bmcl.2008.12.01118. G. C. Tron, T. Pirali, R. A. Billington, P. L. Canonico, G. Sorba and A. A. Genazzani, Click chemistry reactions in medicinal chemistry: Applications of the 1,3-dipolar cycloaddition between azides and alkynes, Med. Res. Rev. 28 (2008) 278–308; DOI: 10.1002/med.20107.http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000253353900006&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f310.1002/med.2010719. J. A. Demaray, J. E. Thuener, M. N. Dawson and S. Sucheck, Synthesis of triazole-oxazolidinones via a one-pot reaction and evaluation of their antimicrobial activity, J. Bioorg. Med. Chem. Lett. 18 (2008) 4868–4871; DOI: 10.1016/j.bmcl.2008.07.087.10.1016/j.bmcl.2008.07.087http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000259144900026&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f320. J. Wu, N. Green, R. Hotchandani, Y. Hu, J. Condon, A. Huang, N. Kaila, H. Q. Li, S. Guler, W. Li, S. Y. Tam, Q. Wang, J. Pelker, S. Marusic, S. Hsu, J. P. Hall, J. B. Telliez, J. Cui and L. L. Lin, Selective inhibitors of tumor progression loci-2 (Tpl2) kinase with potent inhibition of TNF-a production in human whole blood, Bioorg. Med. Chem. Lett. 19 (2009) 3485–3488; DOI: 10.1016/j.bmcl.2009.05.009.http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000266822800028&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f310.1016/j.bmcl.2009.05.00921. C. Gill, G. Jadhav, M. Shaikh, R. Kale, A. Ghawalkar, D. Nagargoje and M. Shiradkar, Clubbed[1,2,3] triazoles by fluorine benzimidazole: A novel approach to H37Rv inhibitors as a potential treatment for tuberculosis, Bioorg. Med. Chem. Lett. 18 (2008) 6244–6247; DOI: 10.1016/j.bmcl.2008.09.096.10.1016/j.bmcl.2008.09.096http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000260789600050&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f322. M. M. Kamel and N. Y. Megally Abdo, Synthesis of novel 1,2,4-triazoles, triazolothiadiazines and triazolothiadiazoles as potential anticancer agents, Eur. J. Med. Chem. 86 (2014) 75–80; DOI: 10.1016/j.ejmech.2014.08.047.http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000343781800008&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f310.1016/j.ejmech.2014.08.04723. Y. P. Hou, J. Sun, Z. H. Pang, P. C. Lv, D. D. Li, L. Yan, H. J. Zhang, E. X. Zheng, J. Zhao and H. L. Zhu, Synthesis and antitumor activity of 1,2,4-triazoles having 1,4-benzodioxan fragment as a novel class of potent methionine aminopeptidase type II inhibitors, Bioorg. Med. Chem. 19 (2011) 5948–5954; DOI: 10.1016/j.bmc.2011.08.063.http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000295494600003&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f310.1016/j.bmc.2011.08.06324. H. Wamhoff, M. Ertas and S. M. S. Atta, Notizen heterocyclic β-enamino esters, 39. Synthesis of 1H-pyrazolo[3,4-d]pyrimidines, Liebigs Ann. Chem. 9 (1985) 1910–1916; DOI: 10.1002/jlac.198519850918.10.1002/jlac.19851985091825. P. Skehan, R. Storeng, D. Scudiero, A. Monks, J. McMahon, D. Vistica, J. T. Warren, H. Bokesch, S. Kenny and M. R. Boyd, New colorimetric cytotoxicity assay for anti-cancer drug screening, J. Natl. Cancer Inst. 82 (1990) 1107–1112; DOI: 10.1093/jnci/82.13.1107.10.1093/jnci/82.13.110726. A. Monks, D. Scudiero, P. Skehan, R. Shoemaker, K. Paul, D. Vistica, C. Hose, J. Langley, P. Cronise, A. Vaigro-Wolff, M. Gray-Goodrich, H. Campbell, J. Mayo and J. M. Boyd, Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines, J. Natl. Cancer Inst. 83 (1991) 757–766; DOI: 10.1093/jnci/83.11.757.10.1093/jnci/83.11.75727. M. J. Weinstein and G. H. Wagman, Plant-derived Antibiotics, in Antibiotics Isolation, Separation and Purification (Ed. L. A. Mitscher), Elsevier, Amsterdam 1978, p. 464.28. H. Naeimi, Z. S. Nazifi, S. M. Amininezhad and M. Amouheidari, Synthesis, characterization and in vitro antimicrobial activity of some new Schiff bases and their complexes, J. Antibiot. 66 (2013) 687–689; DOI: 10.1038/ja.2013.73.http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000327677600011&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f310.1038/ja.2013.7329. P. G. Baraldi, H. El-Kashef, A. Farghaly, P. Vanelle and F. Fruttarolo, Synthesis of new pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines and related heterocycles, Tetrahedron 60 (2004) 5093–5104; DOI: 10.1016/j.tet.2004.04.010.10.1016/j.tet.2004.04.010
Journal
Acta Pharmaceutica – de Gruyter
Published: Sep 1, 2017